×
  • Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Heart Health Products Market

    ID: MRFR/F-B & N/1872-HCR
    110 Pages
    Sakshi Gupta
    October 2025

    Heart Health Products Market Research Report Information By Type (Grains & Pulses, Fruits and Vegetables), By Application (Child and Adult), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Heart Health Products Market Infographic
    Purchase Options

    Heart Health Products Market Summary

    As per MRFR analysis, the Heart Health Products Market was estimated at 18.77 USD Billion in 2024. The Heart Health Products industry is projected to grow from 19.86 USD Billion in 2025 to 34.94 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.81 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Heart Health Products Market is experiencing a dynamic shift towards preventive health and technological integration.

    • North America remains the largest market for heart health products, driven by a growing aging population and increased healthcare expenditure.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising awareness of heart health among consumers.
    • Grains and pulses dominate the market segment, while fruits are rapidly gaining traction as a preferred choice for health-conscious consumers.
    • The focus on preventive healthcare and technological advancements are key drivers propelling market growth.

    Market Size & Forecast

    2024 Market Size 18.77 (USD Billion)
    2035 Market Size 34.94 (USD Billion)
    CAGR (2025 - 2035) 5.81%

    Major Players

    Bayer AG (DE), Pfizer Inc (US), Johnson & Johnson (US), Novartis AG (CH), Abbott Laboratories (US), Amgen Inc (US), Merck & Co Inc (US), Bristol-Myers Squibb Company (US)

    Heart Health Products Market Trends

    The Heart Health Products Market is currently experiencing a dynamic evolution, driven by a growing awareness of cardiovascular health among consumers. This heightened consciousness is prompting individuals to seek preventive measures and solutions that promote heart wellness. As a result, a diverse array of products, including supplements, functional foods, and advanced medical devices, is emerging to cater to this increasing demand. Furthermore, the integration of technology into heart health solutions, such as wearable devices and mobile applications, appears to enhance consumer engagement and adherence to health regimens. This trend indicates a shift towards a more proactive approach to heart health management, where individuals are empowered to monitor and improve their cardiovascular well-being. In addition, the Heart Health Products Market is witnessing a notable rise in the popularity of plant-based and natural ingredients. Consumers are increasingly inclined to choose products that align with their health-conscious lifestyles, favoring those that are perceived as safe and effective. This inclination towards natural solutions suggests a potential transformation in product formulations, with manufacturers likely to innovate and adapt to meet these evolving preferences. Overall, the Heart Health Products Market is poised for continued growth, driven by consumer demand for effective, accessible, and innovative heart health solutions.

    Technological Integration

    The incorporation of technology into heart health products is becoming increasingly prevalent. Wearable devices and mobile applications are facilitating real-time monitoring of cardiovascular health, allowing users to track vital metrics and receive personalized feedback. This trend not only enhances user engagement but also promotes adherence to health recommendations, potentially leading to improved outcomes.

    Natural Ingredients

    There is a growing consumer preference for products that utilize plant-based and natural ingredients. This shift reflects a broader trend towards holistic health and wellness, as individuals seek solutions that are perceived as safer and more effective. Manufacturers are likely to respond by reformulating existing products and developing new offerings that align with these preferences.

    Preventive Health Focus

    The Heart Health Products Market is increasingly oriented towards preventive health measures. Consumers are becoming more proactive in managing their cardiovascular health, seeking products that support long-term wellness rather than merely addressing existing conditions. This trend suggests a significant shift in consumer behavior, emphasizing the importance of prevention in heart health.

    Heart Health Products Market Drivers

    Aging Population

    The aging population is a pivotal driver for the Heart Health Products Market. As individuals age, the prevalence of cardiovascular diseases tends to increase, leading to a heightened demand for heart health products. According to recent statistics, nearly 80 percent of individuals aged 65 and older have at least one chronic health condition, with heart disease being among the most common. This demographic shift necessitates innovative solutions and products tailored to the needs of older adults. Consequently, companies within the Heart Health Products Market are likely to focus on developing specialized products that cater to this growing segment, potentially enhancing their market share and profitability.

    Technological Advancements

    Technological advancements are transforming the Heart Health Products Market, enabling the development of innovative products that enhance cardiovascular health. Wearable devices, such as fitness trackers and smartwatches, are increasingly popular, allowing consumers to monitor their heart rates and overall health in real-time. Furthermore, advancements in telemedicine and mobile health applications facilitate remote monitoring and consultations, making heart health management more accessible. The integration of artificial intelligence in health products is also on the rise, providing personalized recommendations based on individual health data. These technological innovations not only improve consumer engagement but also drive growth within the Heart Health Products Market.

    Focus on Preventive Healthcare

    The focus on preventive healthcare is increasingly shaping the Heart Health Products Market. With a shift towards proactive health management, consumers are more inclined to invest in products that prevent heart-related issues rather than solely treating them. This trend is supported by a growing body of research emphasizing the importance of lifestyle changes and dietary modifications in maintaining heart health. As a result, the market for heart health products, including dietary supplements and functional foods, is expanding. Industry analysts project that this segment will experience robust growth, driven by consumer demand for preventive solutions. The Heart Health Products Market is thus likely to see a surge in innovative offerings that align with this preventive approach.

    Increased Healthcare Expenditure

    Increased healthcare expenditure is a crucial driver for the Heart Health Products Market. As healthcare systems evolve, there is a notable rise in spending on preventive health measures, including heart health products. Governments and private sectors are investing more in health promotion and disease prevention, recognizing the long-term benefits of reducing the burden of cardiovascular diseases. This trend is reflected in the growing market for heart health supplements and devices, which are becoming integral components of healthcare strategies. The Heart Health Products Market stands to gain from this increased investment, as consumers are more likely to seek out products that support their cardiovascular health.

    Rising Awareness of Heart Health

    There is a growing awareness regarding heart health, which serves as a significant driver for the Heart Health Products Market. Educational campaigns and health initiatives have increased public knowledge about the risks associated with heart disease and the importance of preventive measures. This heightened awareness has led to an increase in consumer demand for heart health products, including supplements, functional foods, and monitoring devices. Market data indicates that the heart health supplement segment is projected to grow at a compound annual growth rate of approximately 7 percent over the next five years. As consumers become more proactive about their health, the Heart Health Products Market is poised to benefit from this trend.

    Market Segment Insights

    Heart Health Products Type Insights

    The Heart Health Products market segmentation, based on type, includes Grains & Pulses, Fruits, and Vegetables. The grain and pulses segment dominates the market, accounting for the largest market revenue as they reduce blood pressure and enhance overall cardiovascular health. Grains and pulses are food that is plant-based, high in fiber, minerals, vitamins, and other crucial nutrients possessing various health benefits, like improved health of the heart. The consumption of legumes and grains also helps minimize cholesterol levels and minimizes coronary artery disease risk.

    Heart Health Products Application Insights

    The Heart Health Products market segmentation, based on application, includes Children and Adults. The children segment dominates the market segment due to the increasing awareness about the nutritional food of children, rising preference for cereals over other foods, and growing consumption of milk products and milk. Cholesterol levels in children can be reduced, which will be helpful in reducing the risk for heart diseases later in life, with heart health products consumption. It can also assist in enhancing overall cardiovascular health by giving essential nutrients beneficial for the heart, like omega-3 fatty acids and antioxidants.

    Heart health products can also reduce inflammation, which leads to heart diseases, improving the overall well-being of children. The adult segment is anticipated to witness the highest growth rate during the forecast period.

    Figure 1: Heart Health Products Market, by Application, 2022 & 2032 (USD Billion)

    Get more detailed insights about Heart Health Products Market

    Regional Insights

    North America : Leading Market for Innovation

    North America is the largest market for heart health products, accounting for approximately 45% of the global market share. The region benefits from advanced healthcare infrastructure, high disposable incomes, and increasing awareness of heart health. Regulatory support from agencies like the FDA has catalyzed innovation and the introduction of new products, driving demand. The growing prevalence of cardiovascular diseases further fuels market growth, making it a key area for investment and development. The United States is the leading country in this region, with significant contributions from major players such as Pfizer Inc, Johnson & Johnson, and Merck & Co Inc. Canada also plays a vital role, focusing on preventive care and innovative treatments. The competitive landscape is characterized by a mix of established pharmaceutical giants and emerging biotech firms, all striving to capture market share in this lucrative sector.

    Europe : Regulatory Framework Enhances Growth

    Europe is the second-largest market for heart health products, holding around 30% of the global market share. The region's growth is driven by an aging population, increasing healthcare expenditure, and a strong regulatory framework that encourages innovation. The European Medicines Agency (EMA) plays a crucial role in ensuring the safety and efficacy of heart health products, which boosts consumer confidence and market demand. Additionally, initiatives aimed at reducing cardiovascular diseases are propelling market expansion. Leading countries in Europe include Germany, France, and the United Kingdom, which are home to several key players like Bayer AG and Novartis AG. The competitive landscape is marked by a blend of multinational corporations and local firms, all vying for a share of the growing market. Collaborative efforts between public health organizations and private companies are also enhancing product development and distribution, further solidifying Europe's position in the heart health sector.

    Asia-Pacific : Emerging Market with High Potential

    The Asia-Pacific region is rapidly emerging as a significant player in the heart health products market, accounting for approximately 20% of the global share. Factors such as rising disposable incomes, urbanization, and increasing awareness of heart health are driving demand. Governments in countries like China and India are implementing policies to combat cardiovascular diseases, which is expected to further stimulate market growth. The region's diverse population presents unique challenges and opportunities for tailored heart health solutions. China and Japan are the leading countries in this region, with a growing presence of both local and international companies. Key players like Abbott Laboratories and Amgen Inc are actively investing in research and development to cater to the specific needs of the population. The competitive landscape is evolving, with a focus on innovative therapies and preventive measures, making Asia-Pacific a promising market for heart health products.

    Middle East and Africa : Untapped Market Opportunities

    The Middle East and Africa region is in the early stages of developing its heart health products market, currently holding about 5% of the global market share. The growth is driven by increasing awareness of cardiovascular diseases, rising healthcare investments, and government initiatives aimed at improving public health. Countries like South Africa and the UAE are leading the charge, with efforts to enhance healthcare infrastructure and access to heart health products. The region's diverse economic landscape presents both challenges and opportunities for market players. South Africa is the largest market in this region, with a growing number of local and international companies entering the space. The competitive landscape is characterized by a mix of established pharmaceutical firms and emerging startups focused on innovative heart health solutions. Collaborative efforts between governments and private sectors are essential for addressing the unique health challenges faced by the region, paving the way for future growth in the heart health market.

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Heart Health Products market grow even more. Market players are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Heart Health Products industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Heart Health Products industry to benefit clients and increase the market sector. In recent years, the Heart Health Products industry has offered some of the most significant advantages to the healthcare industry.

    Major players in the Heart Health Products market, including United Agricultural Services Laboratories, Koninklijke DSM NV, Kerry, USANA Health Science Inc., Nature’s Way Products Inc., Irwin Naturals, Asterism Healthcare Group, Advanced Orthomolecular Research, GNC Holdings Inc., Maritzmayer Laboratories Inc., and others, are trying to increase market demand by investing in research and development operations.

    United Agricultural Services Laboratories, commonly known as UAS Laboratories, founded in the year 1979, and headquartered in Wisconsin, USA, is a private biotechnology company. The company formulates and markets probiotics for the domestic as well as international markets. The company offers trusted probiotic-based facilities via innovative applications of quality, science, and talent, which helps in healthy living while exceeding stakeholder expectations. The company's expertise in semi-finished and raw-material offerings of probiotic-based supplements and private labeling, offering biotechnology, emphasized research on the health of the humans and the healthcare industry.

    In 2020, UAS Laboratories LLC was acquired by Hansen Holdings AS in order to strengthen the human health business of the latter company. This acquisition will assist the company in improving its product portfolio of the company and will also expand the microbial platform and human health business.

    Koninklijke DSM NV, a Dutch multinational corporation established in 1902, is a science-based company that emphasizes nutrition, health, and bioscience. The nutrition business of the company comprises DSM nutritional products and DSM food specialists. The company offers solutions for the people and planet's health and screens the sections like animal nutrition and health, beverage and food, medical nutrition, pharmaceuticals, nutrition improvements, early life nutrition, dietary supplements, and personal care. In 2019, KONINKLIJKE DSM NV acquired AVA in order to improve its position in the personalized nutrition section, as the company offers tailored solutions for heart health to its customers.

    Key Companies in the Heart Health Products Market market include

    Industry Developments

    March 2024 –The Food and Drug Administration on March 23rd approved Wegovy manufacturer Novo Nordisk's application to add cardiovascular advantages to the weight-loss drug's label. The decision makes Wegovy the first weight-loss drug to be advertised to inhibit cardiovascular events such as heart attack or stroke. Novo Nordisk President Doug Langa said in a statement that they identify how crucial this moment is for the millions of people who live with extra weight or obesity and known heart disease. The company will continue to advance options that put their needs first. The label extension is anticipated to enhance insurance coverage for Wegovy -- the sister drug to Novo Nordisk's better-known Ozempic – which is worth more than USD1,300 per month out of pocket. Several insurers, including Medicare, don't cover drugs for weight loss. A cardiologist and scientist at Yale University and Yale New Haven Hospital, Dr. Harlan Krumholz, stated that the significance of Wegovy is "not about appearance but about health. " She said that the proof is that they lower the risk and save lives, so it is invalid to deny people access to medications that will directly improve their health. The FDA authorization is based on a 17,000-patient study that explained that people who took Wegovy had a 20% lower risk of cardiac events than people who took a placebo. Wegovy is shown for people who are considered obese -- body mass index of 30 -- or overweight -- BMI of 27 -- and have at least one "weight-related" condition such as high cholesterol or blood pressure. The director of the FDA's Division of Diabetes, Lipid Disorders, and Obesity, Dr. John Sharretts, said in a statement that this patient population has a greater risk of cardiovascular death, heart attack and stroke. He further said that offering a treatment option that is established to reduce this cardiovascular risk is a major advance for public health.

    February 2022: The acquisition of Pharma foods international Co was announced by Kerry. This acquisition will fuel the manufacturing capabilities of the company.

    January 2018: USANA Health Sciences Inc. started to expand its presence throughout Europe to increase its footprint. The company expanded its presence by opening subsidiaries in Romania, Germany, Spain, and Italy, from roughly 20 to 24 markets globally.

    February 2017: By-Health and Koninklijke NV collaborated to introduce new cardiovascular health products consisting of tomato extract ingredients, Fruitflow. This collaboration will help the company to meet the regulations and standards of China.

    Future Outlook

    Heart Health Products Market Future Outlook

    The Heart Health Products Market is projected to grow at a 5.81% CAGR from 2024 to 2035, driven by increasing health awareness, technological advancements, and aging populations.

    New opportunities lie in:

    • Development of personalized heart health supplements based on genetic profiling.
    • Expansion of telehealth services for remote heart health monitoring.
    • Integration of AI-driven analytics in heart health product development.

    By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

    Market Segmentation

    Heart Health Products Type Outlook

    • Grains & Pulses
    • Fruits
    • Vegetables

    Heart Health Products Regional Outlook

    • {"North America"=>["US"
    • "Canada"]}
    • {"Europe"=>["Germany"
    • "France"
    • "UK"
    • "Italy"
    • "Spain"]}
    • {"Rest of Europe"=>["Asia-Pacific"
    • "China"
    • "Japan"
    • "India"
    • "Australia"
    • "South Korea"]}
    • {"Rest of Asia-Pacific"=>["Rest of the World"
    • "Middle East"
    • "Africa"
    • "Latin America"]}

    Heart Health Products Application Outlook

    • Child
    • Adult

    Report Scope

    MARKET SIZE 202418.77(USD Billion)
    MARKET SIZE 202519.86(USD Billion)
    MARKET SIZE 203534.94(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)5.81% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesIntegration of wearable technology enhances monitoring and management in the Heart Health Products Market.
    Key Market DynamicsRising consumer awareness drives demand for innovative heart health products amid evolving regulatory standards and competitive pressures.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Market Highlights

    Author
    Sakshi Gupta
    Research Analyst Level II

    I have about two years of experience working in the consumer goods and retail industries and I am a biotech graduate.A tech-savvy analytically focused professional with a strong capabilities in identification, concept generation, and strategy evaluation. I can produce data-driven solutions while fusing unusual viewpoints with original concepts. I have been extensively working on business case studies, competitive & comparative analyses, and strategic reports. My primary areas of experience include client management, financial analysis, supply chain evaluation, market entry strategy evaluation, and estimating and forecasting market size.

    Leave a Comment

    FAQs

    How much is the Hearth Health Products market?

    The Hearth Health Products market size was valued at USD 17.6 Billion in 2023.

    What is growth rate of the Hearth Health Products market?

    The market is foreseen to grow at a CAGR of 5.81% during the forecast period, 2024-2032.

    Which region held largest market share in the Hearth Health Products market?

    North America had the largest share of the market

    Who are the key players in the Hearth Health Products market?

    The key players in the market are United Agricultural Services Laboratories, Koninklijke DSM NV, Kerry, USANA Health Science Inc., Nature’s Way Products Inc., Irwin Naturals, Asterism Healthcare Group, Advanced Orthomolecular Research, GNC Holdings Inc., Maritzmayer Laboratories Inc.

    Which type led the Hearth Health Products market?

    The grain and pulses category dominated the market in 2023.

    Which application had largest market share in the Hearth Health Products market?

    The child category had the largest share in the market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions